Schwann cells play an important role in both the development and regeneration of peripheral nerves. Proliferation and differentiation of Schwann cells are critically dependent on changes in the levels of cAMP. ATP is a fast excitatory transmitter in the peripheral nervous system, inducing depolarization of the vagus nerve through occupancy of P # -purinergic receptors. In the present study we demonstrate that extracellular ATP stimulates phospholipase C and inhibits adenylate cyclase activities in cultured Schwann cells. Addition of ATP inhibited, in a concentration-dependent manner, forskolin-or isoprenalinestimulated adenylate cyclase activity. The rank order of potency corresponding to different purinergic receptor agonists was 2-methylthio-ATP ATP l ADP adenosine 5h- [γ-thio] 
INTRODUCTION
Schwann cells are localized at the nodes of Ranvier and have an important role in the production and maintenance of the myelin sheath. Characterization of receptor-mediated signaltransduction pathways in Schwann cells and their role in Schwann-cell proliferation and myelination is a key element in understanding their influence in nerve function under normal and pathological conditions. Several reports have established that changes in cAMP levels are involved in the regulation of both proliferation and differentiation in primary [1] [2] [3] and immortalized [4, 5] Schwann cells. It has been proposed that cAMP elevation (likely induced by axon-associated factors), acts as a primary signal that synergizes with growth factors in driving Schwann-cell proliferation. On the other hand, withdrawal from the cell cycle (by poorly understood mechanisms) acts as a secondary signal that, superimposed on increased cAMP levels, induces differentiation and myelination (for review see [6] ). The list of physiological agents reported to increase cAMP levels in primary Schwann cells is limited to β " -adrenergic agonists, vasoactive intestinal peptide and secretin [7] . On the other hand, the mitogenic effects triggered by axolemma-derived fractions and glial growth factor seem to involve protein kinase C activation [8, 9] .
Purinergic receptors are widely distributed and mediate several responses, including vasodilation, proliferation, muscle con- ]pA were ineffective. These results demonstrate that immortalized Schwann cells express P #u and P #y purinoceptors, which are coupled to stimulation of phospholipase C and inhibition of adenylate cyclase, respectively. Our observations unveil signal-transduction pathways that may be used by ATP to regulate proliferation and differentiation of Schwann cells, and ultimately to influence nerve homoeostasis. traction or relaxation, secretion and modulation of ion transport. In the nervous tissue, ATP can either act as a neurotransmitter or modulate the release and action of other neurotransmitters (for review see [10] ). The action of extracellular ATP on the modulation of neuronal signal-transduction systems involves an increase in Ca# + uptake, activation of phospholipase A # , C and D, and changes in the levels of cAMP and cGMP. In peripheral nerve, ATP can be released at the nerve terminals and also from damaged nerves. However, little is known about the role of this nucleotide in the regulation of Schwann-cell function. We now report that ATP and adenosine 5h-[γ-thio]triphosphate ([ATP [S] ) activate the release of inositol phosphates and inhibit adenylate cyclase activity by a pertussis-toxin-sensitive mechanism in a rat Schwann cell line. A preliminary account of these results has been presented in abstract form [11] . (20 mCi\mmol) and [α-$#P]ATP were purchased from DuPont-NEN Products (Boston, MA, U.S.A.). Pertussis toxin was obtained from List Laboratories (Campbell, CA, U.S.A.). Polyethyleneimine-cellulose plates were obtained from Sigma (St. Louis, MO, U.S.A.). Analytical-grade anionexchange resin AG1-X8 (200-400 mesh, chloride form) was obtained from Bio-Rad. Immortalized Schwann cells were kindly provided by Dr. Seth Porter (Syntex, Palo Alto, CA, U.S.A.). The anti-cAMP antiserum was kindly given by Dr. Kevin Catt (NICHD\NIH, Bethesda, MD, U.S.A.).
MATERIALS AND METHODS

Materials
myo-[2-$H]Inositol
Cell culture
Immortalized Schwann cells were routinely grown in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10 % fetal-calf serum in 75 cm# flasks, as previously described [12] . These cells, although defective in growth control, associate with axons in culture, deposit a basal lamina and ensheath and myelinate axons, retaining most, if not all, of the functional capabilitites of primary Schwann cells [13] . Cells were subcultured into 12-well plates for experiments aimed at measuring cAMP accumulation or phosphoinositide breakdown. For measurement of intracellular free Ca# + ([Ca# + ] i ), cells were plated on 12 mm glass cover-slips. To minimize variations, cells were routinely used at the same passage number, 48-72 h after plating. Under these conditions, the cultures were consistently 80-100 % confluent, with few or no cell aggregates.
Determination of phosphoinositide metabolism
Cells were labelled with [$H]inositol (1 µCi\well) in serum-and inositol-free DMEM for approx. 16-20 h before the experiment. In some experiments, pertussis toxin (0.1 µg\ml) was also added during the labelling period. After labelling, cells were washed for 1 h in DMEM, followed by removal of media and addition of 1 ml of Hanks' Balanced Salt Solution (HBSS) containing 10 mM LiCl and 10 mM glucose. Unless otherwise indicated, the concentrations of Mg# + and Ca# + in the HBSS solution were 0.9 and 1.2 mM respectively. Cells were preincubated for 15 min, followed by addition of the desired agonists (10 µl) and further incubation for an additional 30 min. The reaction was stopped by removal of the media and addition of 500 µl of methanol\HCl (100 : 1, v\v). Cells were scraped and transferred to glass tubes containing 1 ml of chloroform and 25 µg of phytic acid hydrolysate to give final proportions of chloroform :methanol :water of 10 : 5 : 4 (by vol.). After separation, the upper phase was removed and subjected to chromatography on AG1-X8 Dowex columns (chloride form) as previously described [14] . Briefly, InsP, InsP # and InsP $ were eluted with 30 mM, 90 mM and 0.5 M HCl respectively, and radioactivity in each fraction was measured by scintillation spectroscopy. Lower phases were washed with 500 µl of theoretical upper phase (chloroform :methanol :water, 3 : 47 : 48, by vol.) containing 1 mM myo-inositol, and dried down under nitrogen. Dried extracts were resuspended in 300 µl of chloroform :methanol :water (75 : 25 : 2, by vol.) and duplicate 30 µl samples were counted for radioactivity.
Fura-2 loading and microfluorimetry
Schwann cells were washed once with HBSS and incubated at 37 mC with 1 µM fura-2 acetoxymethyl ester (fura-2\AM) for 45-60 min to allow entrapment and hydrolysis of the fura-2 ester. After loading, the cover-slips were washed and mounted in a perfusion chamber on the stage of an upright fluorescence microscope. The loaded cells were assayed within 90 min from the end of loading. Microfluorimetry was performed as previously described [15] . Briefly, cells were illuminated alternatively with 340 and 380 nm-wavelength light through the epifluorescence optics of the microscope. The fluorescence signal was normalized by calculating the ratio of the emission intensity after excitation at 340 and 380 nm. This ratio is a function of the [Ca# + ] i and independent of the fura-2 concentration. Conversion of the fura-2 ratio into [Ca# + ] i was accomplished by a calibration curve which was constructed with fura-2 in a solution containing 0.15 mM KCl, 1 mM EGTA, 10 mM Mops buffer, pH 7.4, and appropriate concentrations of CaCl # to yield 50-1000 µM free Ca# + .
Measurement of cAMP levels
Schwann cells were serum-deprived 3-6 h before the start of experiments. In some cases, cells were treated with pertussis toxin for 16-20 h, as described for measurement of phosphoinositide metabolism. At the beginning of the experiment, the medium was removed and 1 ml of 500 µM isobutylmethylxanthine in DMEM was added. After a 5 min preincubation, the desired agonists were added and the cells further incubated for 15 min. At the end of this period, the media were removed, followed by three washes with ice-cold Dulbecco's PBS and addition of 500 µl of boiling 50 mM sodium acetate, pH 6.0. Cells were scraped and transferred to microfuge tubes. The tubes were placed in boiling water for 10 min. cAMP was measured by radioimmunoassay [16] .
Determination of ecto-nucleotidase activity
[α-$#P]ATP breakdown was measured as an estimation of ectonucleotidase activity. Cells were subcultured in 12-well plates as described above. After 48 h, the medium was replaced by serumfree DMEM and cells were incubated for 15 h. After removal of the media, 500 µl portions of HBSS containing 10 mM LiCl, 10 mM glucose and variable amounts of Mg# + and Ca# + were added. After 15 min preincubation, a second 500 µl portion of the respective HBSS solutions containing 0.36 µCi of [α-$#P]ATP and increasing concentrations of unlabelled ATP was added. Samples of the media (2.5 µl) were removed at 0, 5, 15, 30 and 60 min. Separation of hydrolysis products was performed by TLC on polyethyleneimine-cellulose plates, with 1 M LiCl as running solvent (internal standards of unlabelled nucleotides were added to each sample). Radioactive spots were detected by autoradiography, cut out and counted by liquid scintillation.
RESULTS cAMP accumulation
Schwann cells incubated in the presence of forskolin or isoprenaline displayed a significant increase in the accumulation of cAMP ( Table 1 ). Addition of ATP or ATP[S], ineffective by itself (results not shown), resulted in approx. 50-75 % inhibition of isoprenaline-or forskolin-stimulated cAMP production respectively (Table 1 ). This inhibitory effect of ATP was concentration-
Table 1 Effect of ATP on forskolin-or isoprenaline-stimulated cAMP accumulation in immortalized Schwann cells
Schwann cells were incubated for 12 h in serum-free DMEM. Cells were subsequently washed and incubated for 15 min with the indicated concentrations of forskolin or isoprenaline in the presence or absence of ATP. Samples were processed as described in the Materials and methods section. Each value represents the meanpS.E.M. of triplicate incubations. Symbols show significant differences from control (**) or from forskolin or isoprenaline ( †) at P 0.01, as determined by Student's t test.
cAMP (pmol/mg of protein)
72.0p5.9** Forskolin (5 µM)jATP (100 µM) 37.9p5.0 † Isoprenaline (10 µM 49.8p5.8** Isoprenaline (10 µM)jATP (100 µM)
18.6p0.9 † 
Figure 1 Concentration-response curves corresponding to the effects of nucleotides on isoprenaline-stimulated cAMP accumulation in Schwann cells
Cells were serum-deprived for 12 h and incubated in the presence of 100 µM isoprenaline and the indicated concentrations of nucleotides. Results shown represent cAMP accumulation relative to that measured with 100 µM isoprenaline alone. Samples were processed as described in the Materials and methods section. (Figure 1 ). We also examined the pharmacological specificity of this inhibitory effect. The rank order of potency corresponding to different ATP analogues was 2-methylthio-ATP (2MeSATP) ATP l ADP ATP[S] UTP, consistent with the involvement of a P #y purinergic-receptor subtype (Figure 1 ). Adenosine and adenosine 5h-[α,β-methylene]triphosphate (pp[CH # ]pA) were ineffective (results not shown). Incubation of cells in the presence of pertussis toxin (100 ng\ml) completely blocked the inhibitory effect of ATP on forskolin-and isoprenaline-stimulated cAMP accumulation (only forskolin is shown in Table 2 ). These results indicate that a pertussis-toxin-sensitive G-protein mediates the effects triggered by occupancy of the extracellular ATP receptor present in Schwann cells, and that this receptor probably belongs to the P #y subtype. (Table 4 ). This increase closely followed the kinetics of InsP $ release (Figure 3 ). On the other hand, and similarly to what was observed during InsP-release experiments, addition of either 0.1 mM or 1 mM ATP was ineffective in increasing [Ca# + ] i (results not shown).
Phosphoinositide metabolism
Several ATP analogues were assayed in order to identify further the putative purinergic-receptor subtype involved in the InsP response. The effects of UTP (Table 3) and ADP were similar to that of ATP, whereas AMP and adenosine were ineffective (results not shown). Incubation of Schwann cells in the presence of pp[CH # ]pA or 2MeSATP, selective agonists for the P #x and P #y purinoceptor subtypes respectively, were also ineffective (results not shown).
Interestingly, we observed that removal of Ca# + and Mg# + from the HBSS increased the potency and the efficacy of the effect triggered by ATP and analogues (Table 3 and Figure 2) . However, addition of 1 mM each of EGTA and EDTA to a nominally Ca# + -and Mg# + -free medium (to chelate bivalent cations arising from water and reagents) significantly (Table 5 ). ADP had a moderate effect, whereas 2MeSATP, pp[CH # ]pA and adenosine were ineffective (Table 5 ). Experiments in which Schwann cells were assayed in HBSS + in the presence of up to 2 mM ATP (to generate a concentration of ATP% − equivalent to that in HBSS − containing 100 µM ATP) did not mimic the effect of ATP in HBSS − (results not shown).
Preincubation of the cells with pertussis toxin (100 ng\ml) did not alter significantly the maximum amount of InsP release by 
Determination of ecto-nucleotidase activity
Several reports in the literature have established that various cells in culture exhibit a significant Ca# + -and Mg# + -dependent ecto-nucleotidase activity which is able to hydrolyse ATP to ADP, AMP and adenosine [17] . Such activity could decrease the concentration of ATP during the assays and explain the small effects of this nucleotide in the presence of cations. This possibility was investigated by studying the rate of degradation of [α-$#P]ATP by Schwann cells incubated in HBSS in the presence or absence of 1.2 mM CaCl # and 0.9 mM MgCl # . As shown in Figure 4(a) , when 100 µM [α-$#P]ATP was added in the presence of both cations we observed a significant degradation of the nucleotide, with only 30 % remaining after a 30 min incubation. Omission of Ca# + and Mg# + from the HBSS decreased the degradation by 10 % only at 15 min ; no significant differences were observed at other time points. However, addition of EGTA and EDTA (1 mM each), to chelate Ca# + arising from water and reagents in the medium, completely prevented the breakdown of ATP throughout the 30 min period (results not shown). Degradation of ATP occurred in parallel with a significant increase in the production of ADP and small amounts of AMP (Figure 4b ). Increasing the concentration of unlabelled ATP up to 1 mM did not result in significant changes in the rate of degradation (results not shown). These results suggested that the decreased effect of ATP on InsP release in HBSS + does not result from a decrease in the concentration of this nucleotide during the assay or formation of ADP. Furthermore, when Schwann cells were simultaneously exposed to ATP and ADP (100 µM each) in HBSS − , the release of InsP was similar to that observed in the 
Influence of Ca 2 + influx on ATP-mediated InsP release
We studied whether influx of Ca# + was responsible for the differential effects of ATP\UTP on InsP release in HBSS + and HBSS − media. To this end, we carried out experiments in which Gd$ + , a potent Ca# + -channel blocker, was added to Schwann cells incubated in either buffer (HBSS + or HBSS − ). As shown in Table 6 , addition of 100 µM Gd$ + decreased the basal and nucleotide-stimulated release of InsP, although it did not alter significantly the effect of ATP on this response in Schwann cells incubated in HBSS − . On the other hand, Gd$ + completely abolished the nucleotide effect observed in HBSS + (Table 6) 
DISCUSSION
In the present study, we demonstrated that immortalized Schwann cells express P # purinergic receptors linked to at least two signalling systems : stimulation of phosphoinositide metab- [18] [19] [20] [21] . Sato et al. [22] have observed that ATP inhibits adenylate cyclase and stimulates phospholipase C through different subtypes of P # -purinergic receptors in FRTL-5 thyroid cells. Recently, Boyer et al. [23] reported that a P # -purinergic receptor in C6-2B glioma cells is coupled to inhibition of forskolin-or isoprenalinestimulated adenylate cyclase activity, but does not regulate inositol lipid metabolism. Pharmacological studies have supported the existence of five different receptor subtypes, termed P #x , P #y , P #u , P #t and P #z [10, 17] . ATP, UTP and ADP are endogenous agonists for the P #x , P #y and P #u subtypes. Both methylenephosphonate and phosphorothioate derivatives have been used to distinguish these subtypes. The accepted rank order of potencies is as follows : P #x : pp[CH # ]pA ATP 2MeSATP ; P #y : 2MeSATP ATP l UTP l ATP[S] ; P #u : ATP[S] UTP l ATP ADP ; P #z : the free form of ATP (ATP% − ) is the only active agonist. According to this classification, the inhibition of adenylate cyclase activity by a P # -purinoceptor agonist in immortalized Schwann cells is mediated by a P #y receptor subtype. The nucleotide-dependent stimulation of InsP release is more complex and appears to be mediated by a different receptor subtype, probably a P #u . In addition, the two effects showed different sensitivity to preincubation with pertussis toxin, indicative of coupling through more than one G protein.
The more puzzling result of the present study is that low levels of Ca# + and Mg# + (approx. 10 µM each) enhanced InsP release by ATP or UTP. We thought of, and tested, two possible explanations for this observation. (1) The effects of ATP detected in media containing low Ca# + and Mg# + may be triggered by the interaction of ATP% − with a P #z subtype. The presence of Ca# + and Mg# + (1.2 mM and 0.9 mM respectively) results predominantly in the formation of MgATP# − and CaATP# − , coexisting with low amounts of ATP% − (approx. 4 µM ATP% − in HBSS + , compared with approx. 40 µM in HBSS − ). To test this possibility, we carried out experiments in which Schwann cells were assayed in HBSS + in the presence of up to 2 mM ATP to generate a concentration of ATP% − equivalent to that in HBSS − containing 100 µM ATP (40 µM ATP% − ). However, under these experimental conditions, we did not observe an increase in InsP formation compared with that in HBSS + with 100 µM ATP (results not shown). (2) Cultured Schwann cells exhibit a high ecto-nucleotidase activity, which decreases the effective concentration of ATP during the assay (Figure 4) . Ca# + -and Mg# + -activated ecto-ATPases, which hydrolyse ATP and other nucleotides, have been described on the surface of many cell types [24] . As described above (Figure 4 ), the similar rates of ATP hydrolysis in the presence or absence of cations cannot explain the differential effects of ATP. Furthermore, the results obtained in the presence of Gd$ + or Co# + indicate that Ca# + \Mg# + influx in high Ca# + and Mg# + -containing media is not responsible for the decreased response to nucleotides. An alternative possibility is that these cations may interfere with the binding of nucleotide to the receptor subtype that triggers InsP release. This is suggested by the fact that the ATP-mediated inhibition of cAMP accumulation was not modified when the experiments were carried out in either HBSS − or HBSS + . In this context, Azula et al. [25] have suggested that Ni# + impairs thrombin-induced signal transduction by acting on the agonist and\or its receptor in human platelets. Other plausible explanations for the decreased effect of ATP on InsP release in the presence of bivalent cations include the eventual activation of other signalling pathways, which may lead to inhibition of phospholipase C activation (such as increased phospholipase D activity, resulting in diacylglycerol production and protein kinase C activation). Further studies are needed to test this hypothesis.
Trezise et al. [26] have recently reported that the potency of ATP in triggering depolarization of rat vagus nerve is significantly increased when Ca# + and Mg# + are omitted from the incubation media. In addition, these authors observed changes in the rank order of potency of several ATP analogues in the presence or absence of these bivalent cations. A P #x receptor subtype appeared to be involved when the experiments were carried out in the presence of Ca# + and Mg# + ; a P #y subtype was suggested when the studies were carried out in their absence. The explanation proposed by these authors (although not tested) was that their results reflected differential metabolism of nucleotides involving Ca# + \Mg# + -dependent ecto-nucleotidases.
In peripheral nervous system, ATP released at adrenergic synaptic terminals [27] controls the release of sympathetic transmitter [28] , induces depolarization of isolated vagus nerve [29] and increases the release of inositol phosphates in isolated sciatic nerves [30] . Our results, together with the recent report by Lyons et al. [31] , represent the first observations of nucleotide effects mediated by expression of P # purinergic receptors in Schwann cells.
In conclusion, immortalized Schwann cells express P #u and P #y purinoceptors which are coupled to stimulation of phospholipase C and inhibition of adenylate cyclase. As mentioned above, these two signalling systems play a key role in the mechanisms regulating Schwann-cell proliferation and differentiation. We are currently defining the G-proteins linked to these effects and the role of these signal-transduction pathways in Schwann-cell function.
